(Q36040715)

11 August 2017

1 reference

title

Modafinil: new indications for wake promotion (English)

1 reference

11 August 2017

1 reference

Jonathan R L Schwartz

series ordinal

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Expert Opinion on Pharmacotherapy

11 August 2017

published in

1 reference

11 August 2017

volume

6

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

115-129

1 reference

Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Prevalence and consequences of sleep disorders in a shift worker population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: in vivo voltammetry studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

The process of awakening: a PET study of regional brain activity patterns mediating the re-establishment of alertness and consciousness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. A comparison with dexamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Effect of modafinil on cerebral blood flow of anaesthetised rats. Comparison with amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Clinical pharmacokinetic profile of modafinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Effect of modafinil at steady state on the single-dose pharmacokinetic profile of warfarin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Maintenance of wakefulness test: a polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Subjective and objective sleepiness in the active individual.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

A prospective trial of modafinil as an adjunctive treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Use of provigil for underarousal following TBI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Modafinil for treatment of cognitive side effects of antiepileptic drugs in a patient with seizures and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Modafinil treatment of opioid-induced sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Dosing Regimen Effects of Modafinil for Improving Daytime Wakefulness in Patients With Narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Study of the addictive potential of modafinil in naive and cocaine-experienced rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.1.115

21 January 2018

Identifiers

DOI

10.1517/14656566.6.1.115

1 reference

11 August 2017

1 reference